EDP Sciences logo
Submit your paper
Search
Menu
Home All issues Volume 25 / No 2 (2019) J Oral Med Oral Surg, 25 2 (2019) 19 Full HTML
Open Access
Issue
J Oral Med Oral Surg
Volume 25, Number 2, 2019
Article Number 19
Number of page(s) 7
Section Article original / Original article
DOI https://doi.org/10.1051/mbcb/2019003
Published online 04 April 2019

© The authors, 2019

Licence Creative CommonsThis is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

1 Introduction

Oral mucosal melanoma is a malignant neoplasm of melanocytes. It's a rare entity accounting for only 0.5% of melanomas. There is a slight male predominance, and the median age at diagnosis is 55–66 years. The most common oral cavity sites of melanoma are the palate and maxillary gingiva. Mucosal melanomas, which are biologically distinct from their cutaneous counterpart, are caused by unknown factors. They often emerge from pre-existing benign pigmented lesions [1–3]. The exact mechanism of malignant transformation is still unknown. Cutaneous premalignant melanocytic lesions have been well described [3]. But, clinical and histological features of “oral premalignant melanocytic lesions” are lacking. Several case reports are reported in the English language literature. The aim of this article is to report an additional clinical case of oral malignant melanoma with a history of benign melanosis and to analyze its clinical and histopathological features.

2 Case report

A 37-years old woman presented to our department of oral medicine and oral surgery at Monastir dental clinic with a 3 months history of swelling and bleeding in the right maxillary gingiva. A review of her medical history revealed cervical lymph node tuberculosis treated in 2005 by surgery and antibiotics. The patient had neither personal history of malignancies nor treatment with radiation or chemotherapy. Besides, 15 years earlier, at age of 22 years, she has had pigmented lesion on the hard palate and maxillary gingiva. The lesion was a large brown-black flat patch up to 4 cm in its greatest dimension. The lesion was asymptomatic and the patient was unable to remember how long it was present. An incisional biopsy was made. A final diagnosis of benign melanosis without any atypical melanocytes was rendered. Unfortunately, over the course of the next 15 years the patient was lost.

In 2017, due to the widening of the lesion and the appearance of a gingival mass in front of the right maxillary incisors and canine, the patient consulted again.

Intraoral examination showed multiple lesions in the same places of the old benign melanosis. The lesions were asymmetric, irregularly shaped and nonuniformly pigmented. Their color varied from light brown to black. The bigger patch was spread over the hard palate crossing midline and measured approximately 5 cm. Satellite lesions surrounded it. On the buccal side, a black nodular component was in the center extending from the right central incisior to the right canine. It was ulcerated and bleeding at the slightest touch. The lesion was described as having soft consistency.

On close examination, a slightly elevated dark pigmented plaque component and a non-elevated light brown macular component reached alveolar mucosa. There were no palpable lymph nodes (Fig. 1).

An incisional biopsy was performed. Histological report concluded to malignant melanoma of the gingiva. The patient underwent pertinent imaging studies to assess the primary lesion and its bone invasion and to rule out metastatic lesion. Computed tomography (CT) scan of the head and neck revealed no bony invasion and showed 12 mm submandibular lymph node. Brain CT scan was negative. However thoraco-abdominal CT scan founded no signs of distant metastasis except 2 nonspecific lung micro nodules which have been assigned to tuberculosis (Fig. 2).

Subsequently, the patient was referred to the oncology department. She was considered as clinical stage II (T3N1M0) (Tab. 1). The best treatment would have been total maxillectomy associated to cervical dissection and postoperative radiotherapy if surgical margins were proved positive. But extended lesion and proximity of vital structures declined this decision. So, only 70-gray palliative radiotherapy was performed. Oral mucositis developed later with radiotherapy and healing did not begin until the end of therapy (35 sessions). Xérostomia and radiation-induced dermatitis were the quite mandatory sequela after head and neck radiotherapy (Fig. 3).

At 10 months follow up, no new pigmented areas were noted. Local examination showed lesion's size decrease. But, the nodular component persisted (Fig. 4). Magnetic resonance imaging (MRI) will be programmed in 2 months to better evaluate local control and rule out distant metastasis.

thumbnail Fig. 1

Clinical presentation: A. An extensive pigmented lesion with variegation was seen in the maxillary buccal gingiva and alveolar mucosa from tooth #16 extending to #27 with ulcerated soft and friable nodule of 2 cm long. B. Patchy dark pigmentations were also found in the whole palate.
thumbnail Fig. 2

Computed tomography scan: A. Axial. B. Frontal slices: no bone spread was noted.
Table 1

Clinical staging system for oral malignant melanoma with histopathologic microstaging for stage I (Prasad [20]).

thumbnail Fig. 3

Radiotherapy sequel: A. Xerostomia. B. Radiation induced oral mucositis. C. Radiation induced dermatitis.
thumbnail Fig. 4

Superposition of clinical aspects: A. Clinical presentation at diagnosis. B. 7-months follow up presentation. C. 10-months follow up presentation: decrease in the extent of the lesion.

3 Discussion

Head and neck mucosal melanoma constitute less than 1% of all melanomas and arise for the most part, in two primary sites: the sinonasal region and oral cavity. In the fourth edition of the World Health Organization Classification of Tumors of the Head and Neck, oral and sino-nasal mucosal melanomas are recognized as distinct entities. Oral malignant melanoma (OMM) is the second most common site of occurrence of mucosal melanoma in the head and neck [4,5]. Primary OMM is rare. It represents 0.5% of all oral malignancies and 0.2 to 8% of all melanoma [2]. This prevalence seems to have been stable for 2 centuries. Melanoma is a tumor of the adult. It occurs mostly in the 4th to the 6th decade of life with a range from 4 to 92 years [1,2,4,6–8]. It is often said that there is a slight male predilection of 2:1 [1,2,4,6–8]. Whereas other studies showed no sex predilection, even more there was a female superiority [9,10]. OMM is known to occur more frequently in Japanese, African, and North American Indian populations than in European populations [2,11]. High risk sites are the palate and the maxillary gingiva. However, all oral mucosa sites can be affected by OMM [1,2,4,6–9].

Oral malignant melanoma is usually painless. It is often described as a uniformly pigmented black or brown lesion. But sometimes several shades co-exist: black, brown, gray, pink and red. 10% of oral melanomas are nonpigmented called amelanotic melanoma. The lesions are asymmetric and irregular in outline. Sometimes, they are multiple. The elemental lesion may be a flat macula, a low elevated plaque or a soft nodule. These clinical aspects can be present at the same time [1,2,4]. Tanaka tried to establish a clinical classification and defined 5 types [9]. Unfortunately, this classification has no prognostic value. Ulceration and bleeding are late signs. Unlike squamous cell carcinoma, there is no induration [1,2,4].

So far, the etiology of oral malignant melanoma is poorly understood, unlike cutaneous melanoma which has well-defined risk factors. Therefore, it is still difficult to recognize subjects at highest-risk for developing OMM [5]. Some authors suggest tobacco smoking, inhaled or aspirated environmental carcinogens and chronic irritation as possible risk factors [2].

It is true that most of these tumors appear to be de novo. Haïtami et al. reported three cases of melanoma that appeared on healthy mucosa after dental procedures [5]. However, it needs to be mentioned that about one-third of melanomas have had a history of benign pigmented lesions for months and even years before malignant transformation [1–3]. Unfortunately, the exact mechanism of malignant transformation is unknown. We will present here a non-exhaustive summary of literature cases about melanoma emerging from flat precursor lesions (Tab. 2). To the best of our knowledge, in addition to our clinical case, there are only 7 case reports in English literature which analyze well the clinical and histological features of progression from benign pigmentation to oral malignant melanoma (Tab. 2).

Several descriptive terms have been used to describe premalignant lesions: oral benign melanosis, pre-malignant melanosis, oral melanotic macule, melanocytic dysplasia, melanocytic hyperplasia, neoplastic melanocytic proliferation (Tab. 2) [3,6,12–17]. The average age at diagnosis was 44 years with an interval between 22 and 62 years. No sex predilection was noted. Precursor lesions were irregularly shaped flat, preferentially localized in keratinized tissues, at the same sites of melanomas. Lesions' size ranged from 0.5 to nearly 5 cm of major axis. Lesions have evolved for months and years and they were characterized by their tendency to recur after excision, persistence and enlargement [3]. It is accepted that clinical evaluation of cutaneous melanocytic lesions is guided by ABCDE criteria. The guidelines evaluate for asymmetry, border irregularity, color variegation, a lesion that exceeds a diameter of 6 mm, and lastly evolution, or change in the lesion over time [2]. Many authors claimed that these criteria do not sit well with oral pigmented lesions. However, most of premalignant lesions including our patient transgressed these criteria when progressing to oral malignant melanoma. According to the western society of teachers of oral pathology (WESTOP), both clinical and histological criteria should be used for the monitoring of pigmented lesions and recognition of potentially malignant ones [18].

Biopsy of oral pigmented lesion is still controversial. Umeda involved the biopsy as well as any procedures before the definitive intervention (such as teeth extraction, incision...), in the bad prognosis of OMM. In his case-control study, there was a statistically significant difference between 5-year survival rate with and without procedures before definitive surgical treatment (p < 0.05). Without biopsy, the 5-year survival rate was of 91.7%. However, it dropped to 25.9% for patients who underwent these procedures [8]. On the other hand, without histological analysis, we can never recognize the exact nature of an oral pigmented lesion. So no early treatment could be started. Until tangible evidence, it is not asserted that biopsy increases the risk of local or distant spread of melanoma [2]. Moreover, when we find melanocytic hyperplasia or dysplasia in histological reports, the entire lesion should be completely excised with clear margins [3,18]. For our patient, the lesion covered the entire palate, and histo-pathological report reported no sign of dysplasia. In principle, incisional biopsy was sufficient. But close clinical follow up had to be maintained.

Histological features of potentially malignant pigmented lesions were multifarious. We can find hyperpigmentation in the basal layers, proliferation of dendritic melanocytes with or without atypia, proliferation of clear cell [3,13,15–17,19]. These data are found in Umeda's gradual enlarging pattern of oral malignant melanoma. Meticulous examination revealed that OMM went through three phases: a nodular phase usually affecting the centre, a slightly elevated, deep brownish-black pigmented plaque phase, and a flat light-brown macular phase [11]. In the macular phase, a simple hyperpigmentation in the basal layer is found. Lentiginous proliferation of dendritic melanocytes without apparent cellular atypia may be also noted. The pigmented plaque lesion contains atypical melanocytes nests or individually proliferating tumor cells in the lower epithelial layers. It's considered pre-invasive phase. Macular and plaque phases form radial growth pattern of OMM [3,11]. Overall, most of premalignant lesions histological findings appear to be consistent with features found in the macular and plaque phases of OMM [3]. Only the nodular phase corresponds to true invasive melanoma when vertical growth pattern begins with spindle- shaped or epithelioid tumor cells in the submucosa [3,11].

So, in OMM cellular morphology shows a wide range of features [1,2,4,8,9,20]. Since histological aspect is non-pathognomonic, and 10% of the melanomas are amelanotic, the diagnosis becomes a heavy task. Immunohistochemistry is strongly indicated. Melanocytes markers commonly used are protein S100, melan-A, tyrosinase, HMB45 [2,4,7,8,20].

OMM treatment is based on surgery with wide clear margins. For the palate, maxillectomy with 3–5 cm margins is recommended [2]. To meet this requirement, it is necessary to extend the excision to the soft palate, the tonsillar pillar, and into the pterygomaxillary space. But, the proximity of vital structures makes this objective difficult. No consensus exists so far. Recently, Umeda suggested excision of the lesion with an intraoral approach and involving at least 1.5 cm of healthy tissue, therapeutic radical neck dissection for stade II tumors and immune-chemotherapy [8]. Radiotherapy as first-line treatment does not exceed surgery. Tanaka reported that primary lesion was controlled in 92.3% of cases with surgery, whereas only 53% cases had controlled primary lesion in radiotherapy group [21]. Post-operative radiotherapy is beneficial in cases with positive surgical margins or a strong likelihood of local or regional recurrence [1,2,10]. It's the most effective treatment modality for palliation which was the case of our patient [2].

Despite improved treatments, OMM prognosis remains poor. The average 5-year overall survival rate varied from 16.6 to 48% in various study [9,10,20]. Moreover, the median survival after diagnosis is estimated at 24 months [4]. Various prognostic factors have been investigated, but nowadays only clinical staging at presentation has been affirmed as the most important predictive factor determining outcome [2,4,9,10,20].

Table 2

Summary of literature case reports: Demographic, clinical and histopathological findings, pathology diagnosis of premalignant melanocytic lesion and time to onset of oral malignant melanoma.

4 Conclusion

Oral malignant melanoma is a rare tumor of the oral cavity. It's renowned for its poor prognosis. Advanced disease at time of diagnosis is the only sure predictor of outcome. So, any suspected melanotic lesion should undergo histological analysis to diagnose OMM in its early stages or at best to rule out premalignant pigmented lesions. Close clinical follow-up of premalignant lesions is also emphasized up to a better understanding of cancerization phenomenon.

Conflicts of interests

The authors declare that they have no conflicts of interest in relation to this article.

References

  1. Chaudhry AP, Hampel A, Gorlin RJ. Primary malignant melanoma of the oral cavity: A review of 105 cases. Cancer 1958;11:923–928. [CrossRef] [PubMed] [Google Scholar]
  2. Mohan M, Sukhadia VY, Pai D, Bhat S. Oral malignant melanoma: Systematic review of literature and report of two cases. Oral Surg Oral Med Oral Pathol Oral Radiol 2013;116:e247–254. [CrossRef] [PubMed] [Google Scholar]
  3. Patel PB, Wright JM, Kang DR, Cheng YL. Longitudinal clinicopathologic data of the progression of oral mucosal melanoma – Report of 2 cases and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol 2018;126(1):e21–e30. [CrossRef] [PubMed] [Google Scholar]
  4. Williams MD. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Mucosal Melanomas. Head Neck Pathol 2017;11:110–117. [CrossRef] [PubMed] [Google Scholar]
  5. Haïtami S, Yahya IB, Kinani L, Badr L. Mélanomes de la cavité buccale : présentation de 3 cas. MBCB 2011;17:271–277. [EDP Sciences] [Google Scholar]
  6. Shen ZY, Liu W, Bao ZX, Zhou ZT, Wang LZ. Oral melanotic macule and primary oral malignant melanoma: Epidemiology, location involved, and clinical implications. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;112:e21–25. [Google Scholar]
  7. de Castro MS et al. Primary oral melanoma: A clinicopathologic review and case presentation. Quintessence Int 2017;48:815–827. [PubMed] [Google Scholar]
  8. Umeda M et al. Treatment and prognosis of malignant melanoma of the oral cavity: Preoperative surgical procedure increases risk of distant metastasis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;106:51–57. [CrossRef] [PubMed] [Google Scholar]
  9. Tanaka N et al. Oral malignant melanoma in Japan. Oral Surg Oral Med Oral Pathol 1994;78:81–90. [CrossRef] [PubMed] [Google Scholar]
  10. Lee G, Baek CH, Choi NY, Chung MK. The prognostic role of the surgical approach and adjuvant therapy in operable mucosal melanoma of the head and neck. Clin Exp Otorhinolaryngol 2017;10:97–103. [Google Scholar]
  11. Umeda M, Shimada K. Primary malignant melanoma of the oral cavity – Its histological classification and treatment. Br J Oral Maxillofac Surg 1994;32:39–47. [PubMed] [Google Scholar]
  12. Rapini RP, Golitz LE, Greer RO Jr., Krekorian EA, Poulson T. Primary malignant melanoma of the oral cavity. A review of 177 cases. Cancer 1985;55:1543–1551. [CrossRef] [PubMed] [Google Scholar]
  13. Taylor CO, Lewis JS. Histologically documented transformation of benign oral melanosis into malignant melanoma: A case report. J Oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surg 1990;48:732–734. [CrossRef] [Google Scholar]
  14. Umeda M, Komatsubara H, Shibuya Y, Yokoo S, Komori T. Premalignant melanocytic dysplasia and malignant melanoma of the oral mucosa. Oral Oncol 2002;38:714–722. [CrossRef] [PubMed] [Google Scholar]
  15. Kahn MA, Weathers DR, Hoffman JG. Transformation of a benign oral pigmentation to primary oral melanoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;100:454–459. [CrossRef] [PubMed] [Google Scholar]
  16. Kaehler KC, Russo PA, Egberts F, Warnke PH, Cerroni L, Hauschild A. Metastatic melanoma of the tongue arising from oral melanosis. Arch Dermatol 2008;144(4):558–60. [Google Scholar]
  17. Meleti M, Mooi WJ, van der Waal I. Melanotic pigmentation of palatal salivary glands as a possible precursor to malignant melanoma: Report of an unusual case. J Oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surg 2010;68:867–869. [CrossRef] [Google Scholar]
  18. Barker BF et al. Oral mucosal melanomas: The Western Society of Teachers of Oral Pathology (WESTOP) Banff Workshop Proceedings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;83:672–679. [CrossRef] [PubMed] [Google Scholar]
  19. O'hana D, Barthélémy I, Baudet-Pommel M, Pham-Dang N, Devoize L. Differential diagnosis of an oral mucosal pigmented lesion: A case of essential melanosis. MBCB 2017;23:156–159. [EDP Sciences] [Google Scholar]
  20. Prasad ML, Patel SG, Huvos AG, Shah JP, Busam KJ. Primary mucosal melanoma of the head and neck: A proposal for microstaging localized, Stage I (lymph node-negative) tumors. Cancer 2004;100:1657–1664. [CrossRef] [PubMed] [Google Scholar]
  21. Tanaka N, Mimura M, Ogi K, Amagasa T. Primary malignant melanoma of the oral cavity: Assessment of outcome from the clinical records of 35 patients. Int J Oral Maxillofac Surg 2004;33:761–765. [CrossRef] [PubMed] [Google Scholar]

All Tables

Table 1

Clinical staging system for oral malignant melanoma with histopathologic microstaging for stage I (Prasad [20]).

In the text
Table 2

Summary of literature case reports: Demographic, clinical and histopathological findings, pathology diagnosis of premalignant melanocytic lesion and time to onset of oral malignant melanoma.

In the text

All Figures

thumbnail Fig. 1

Clinical presentation: A. An extensive pigmented lesion with variegation was seen in the maxillary buccal gingiva and alveolar mucosa from tooth #16 extending to #27 with ulcerated soft and friable nodule of 2 cm long. B. Patchy dark pigmentations were also found in the whole palate.
In the text
thumbnail Fig. 2

Computed tomography scan: A. Axial. B. Frontal slices: no bone spread was noted.
In the text
thumbnail Fig. 3

Radiotherapy sequel: A. Xerostomia. B. Radiation induced oral mucositis. C. Radiation induced dermatitis.
In the text
thumbnail Fig. 4

Superposition of clinical aspects: A. Clinical presentation at diagnosis. B. 7-months follow up presentation. C. 10-months follow up presentation: decrease in the extent of the lesion.
In the text

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.